BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16445711)

  • 21. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prehospital tracheal intubating conditions during rapid sequence intubation: rocuronium versus vecuronium.
    Smith CE; Kovach B; Polk JD; Hagen JF; Fallon WF
    Air Med J; 2002; 21(1):26-32. PubMed ID: 11805764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ORG 9426, succinylcholine or vecuronium: which agent provides "overall superiority" for short outpatient procedures.
    Ginsburg R; Lippmann M
    Anesth Analg; 1993 Apr; 76(4):904-5. PubMed ID: 8096683
    [No Abstract]   [Full Text] [Related]  

  • 24. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium.
    Adamus M; Gabrhelik T; Marek O
    Eur J Anaesthesiol; 2008 Jul; 25(7):589-95. PubMed ID: 18405411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of intratracheal administration of vecuronium in rats, compared with intravenous and intramuscular administration.
    Sunaga H; Kaneko M; Amaki Y
    Anesth Analg; 2006 Sep; 103(3):601-7. PubMed ID: 16931668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rocuronium-induced withdrawal movements associated with different Rocuronium injection method.
    Baek SH; Woo CM; Lee HJ; Yoon JY; Kwon JY; Shin SW
    Paediatr Anaesth; 2008 Jun; 18(6):515-9. PubMed ID: 18312520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pulmonary first-pass uptake of five nondepolarizing muscle relaxants in the pig.
    Beaufort TM; Proost JH; Houwertjes MC; Roggeveld J; Wierda JM
    Anesthesiology; 1999 Feb; 90(2):477-83. PubMed ID: 9952155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No substitute for the intravenous route.
    Donati F; Guay J
    Anesthesiology; 2001 Jan; 94(1):1-2. PubMed ID: 11135714
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
    Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: effects of multiple organ failure.
    Circeo LE; Reeves ST
    South Med J; 2001 Jan; 94(1):36-42. PubMed ID: 11213940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle relaxants in paediatric day case surgery.
    Meakin GH
    Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of SZ1677, a new non-depolarizing steroidal neuromuscular blocking drug, and rocuronium on two laryngeal muscles and the anterior tibial muscle in guinea pigs.
    Michalek-Sauberer A; Nicolakis EM; Vizi ES; Gilly H
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):481-7. PubMed ID: 16548861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molar potency is not predictive of the speed of onset of atracurium.
    Kopman AF; Klewicka MM; Neuman GG
    Anesth Analg; 1999 Oct; 89(4):1046-9. PubMed ID: 10512288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.